| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Erlotinib Hydrochloride | FAERS: 2 | US FAERS | |
| 2 | Allopurinol | FAERS: 1 | US FAERS | |
| 3 | Aspirin, Dipyridamole Drug Combination | FAERS: 1 | US FAERS | |
| 4 | Bisoprolol | FAERS: 1 | US FAERS | |
| 5 | Enalapril | FAERS: 1 | US FAERS | |
| 6 | Glatiramer Acetate | FAERS: 1 | US FAERS | |
| 7 | Lenalidomide | FAERS: 1 | US FAERS | |
| 8 | Liraglutide | FAERS: 1 | US FAERS | |
| 9 | Metformin | FAERS: 1 | US FAERS | |
| 10 | Metoprolol | FAERS: 1 | US FAERS | |
| 11 | Ramipril | FAERS: 1 | US FAERS | |
| 12 | estropipate | FAERS: 1 | US FAERS | |
| 13 | Acetaminophen | OFFSIDES | ||
| 14 | Ciprofloxacin | OFFSIDES | ||
| 15 | Mesalamine | OFFSIDES | ||
| 16 | Quinidine | OFFSIDES | ||
| 17 | Triamterene | OFFSIDES | ||
| 18 | rofecoxib | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.